Guangyuyuan 广誉远
3 significant filings since 31 May 2026: 1 on litigation, 1 on government subsidy and 1 on buyback. The latest, on 15 Jul 2026: 广誉远中药股份有限公司关于重大诉讼的进展公告. 1 unverified report logged, the latest on 11 Jun 2026.
自 31 May 2026 起有 3 份重大公告：litigation 1 份、government subsidy 1 份、buyback 1 份。最新一份（15 Jul 2026）：广誉远中药股份有限公司关于重大诉讼的进展公告。记录了 1 条未经核实的报道，最新一条见于 11 Jun 2026。
No broker reports from the last twelve months are held for this company. Brokers covered 1,185 of the 2,361 SSE listings (50%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 2,361 只 SSE 证券中的 1,185 只（50%）。
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 15 May 2018 | 东兴证券 | 张金洋,缪牧一 | Outperform 增持 | ▲ | Buy 买入 |
| 24 Apr 2018 | 联讯证券 | 李志新 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。